+44 (0) 1223 755950
+1 832 327 7413
Click on the image to see the image legend
Target | Proto-Oncogene Vav (VAV1) |
Clonality | Polyclonal |
Reactivity | Human, Mouse, Rat |
Tested Applications | ELISA, WB |
Host | Rabbit |
Recommended dilutions | WB: 1/500 - 1/3000, IHC: 1/50 - 1/100, ELISA: 1/20000. Optimal dilutions/concentrations should be determined by the end user. |
Conjugation | Unconjugated |
Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human VAV1 around the phosphorylation site of tyrosine 174 (E-I-Y-E-D). |
Isotype | IgG |
Form | Liquid |
Purification | Purified from rabbit antiserum by affinity chromatography using epitope-specific immunogen. |
Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
UniProt Primary AC | P15498 (UniProt, ExPASy) |
UniProt Secondary AC | B4DVK9, M0QXX6, Q15860 |
UniProt Entry Name | VAV_HUMAN |
KEGG | hsa:7409 |
String | 9606.ENSP00000472929 |
Buffer | PBS (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02% sodium azide, 50% glycerol. |
Concentration | 1 mg/ml |
Availability | Shipped within 5-10 working days. |
Note | This product is for research use only. |